ROSE.BA

Healthcare Drug Manufacturers - Specialty & Generic

Instituto Rosenbusch S.A.

ARS 143.50

+3.00 +2.14% today

Price History

Not enough data

Key Stats

Market Cap

6.11B

Avg Volume

19,133

P/E (TTM)

0.73

EPS

ARS 197.76

52W High

ARS 357.00

52W Low

ARS 116.00

Div. Yield

0.0%

Valuation

P/B Ratio

0.80

P/S Ratio

0.90

EV/EBITDA

-2.66

EV/Revenue

1.24

Margins

Gross Margin 2.7%

Operating Margin (27.0%)

Net Margin 2.7%

EBITDA Margin (46.7%)

Growth & Returns

Revenue Growth (YoY)

15.3%

Return on Equity

5.5%

Return on Assets

(13.8%)

Liquidity & Leverage

Current Ratio

1.79

Quick Ratio

0.89

Debt / Equity

0.39

Total Cash

986.43M

Total Debt

3.07B

About

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.